Purchase Order 75N93020P01040

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Research And Diagnostic Systems, Inc. on August 27, 2020, for $24,975.00 for a Luminex MagPix instrument with Xponent 4.3 and NHP XL cytokine Luminex performance premixed kit on a firm fixed-price basis. Place of performance is Minneapolis, Minnesota. The order carries no set-aside designation and is scheduled for ultimate completion on September 27, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Luminex Corp on July 10, 2015, for $4,189.49 to cover MAGPIX maintenance renewal (Serial No. MAGX11136001) under firm fixed-price terms with no set-aside designation. Work is performed in Austin, Texas. The order covers monthly billing over a twelve-month period of performance from August 20, 2015, through August 19, 2016. Agreement number SLA0016024.0 / AMBIS 1736587.</p>

This $6,084 firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions for clinical labs and life science research. The contract is for the provision of microspheres, specific regions, and antibody coupling kits. This award was set aside for small businesses. Luminex has...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Luminex Corp, a manufacturer of biological testing technologies. The $18,260.00 contract is for the delivery of a respiratory pathogen panel and MagPix drive fluid, which support NIAID's clinical testing programs and biomedical research efforts. Luminex, as a prime contractor, has provided specialized multiplexing systems and...

The U.S. federal government awarded a $14,292 firm fixed price purchase order to Luminex Corp for Luminex 200 MAGPLEX beads, with an ultimate completion date of February 10, 2017. The contract was awarded without a set-aside designation on January 3, 2017, and is being performed in Austin, Texas. Luminex Corp, a manufacturer of advanced biological testing technologies, was selected to provide these specialized microspheres, which are critical components used in the company's multiplex diagnostic...

This is a firm fixed-price purchase order awarded to Luminex Corp by the National Institute of Allergy and Infectious Diseases, a civilian agency, for the delivery of a cell analyzer valued at $15,279.02. The contract has an ultimate completion date of August 12, 2021. Luminex Corp is a manufacturer of biological testing technologies, including multiplex diagnostic solutions for clinical laboratories and life science research settings. The company frequently serves as a prime contractor for...

The Defense Department's Medical Supply Chain awarded a $2,899.71 firm fixed-price delivery order to Luminex Corp on September 25, 2025, for the supply of MagPlex Microspheres in a 4 milliliter quantity. The order, which must be completed by September 30, 2025, will be delivered to Luminex's facility in Austin, Texas. This delivery order represents a relatively modest procurement within the broader context of the contractor's federal business, which focuses on advanced biological testing...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Promega Corporation for $19,718.00 on July 28, 2020. The order procures luciferase assay systems and luciferase cell culture lysis 5x reagent (30 ml) under a firm fixed-price structure. Place of performance is Madison, Wisconsin. Ultimate completion is scheduled for August 27, 2020. This purchase order was funded under the Coronavirus COVID-19 National Interest Action Code.</p>

This is a delivery order awarded to Luminex Corp by the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract is for the procurement of 4,564,035,295 MAGPLEXMICROSPHERES in 4 ml units at a firm fixed price of $15,816.60. The award was made without any set-aside designation and has an ultimate completion date of March 25, 2024. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and has provided similar immunology products and...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the procurement of 4,565,284,972 MAGPLEX-AVIDIN MICROSPHERES, 1 ML, with a ceiling value of $2,592.00 and a period of performance through August 1, 2024. The contract does not have a set-aside designation. Luminex, which is a foreign-owned, for-profit manufacturer, has provided various diagnostic testing products,...